Colostrum and bioactive, colostral peptides differentially modulate the innate immune response of intestinal epithelial cells

Journal of Peptide Science

Volumn 16, Issue 1, 2010, Pages 21-30

  Jørgensen, Ann Louise Worsøe ^a   Juul Madsen, Helle Risdahl ^a   Stagsted, Jan ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Bioactive peptides; Colostrum; Gastrointestinal digest; Innate immunity; LPS; NF B stimulation; PAM3CSK4; PGN; TLR

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BACTERIUM LIPOPOLYSACCHARIDE; CARBON; CASEIN; FLUORESCAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PANCREAS ENZYME; PEPSIN A; PEPTIDE; PEPTIDOGLYCAN; PROTEINASE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; COLOSTRUM; CONTROLLED STUDY; DIGESTION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MILK; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN ISOLATION; SIGNAL TRANSDUCTION; SIMULATION;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLOSTRUM; IMMUNITY, INNATE; INTESTINAL MUCOSA; MICE; PEPTIDES;

BACTERIA (MICROORGANISMS); BOVINAE; MURINAE;

EID: 74749104416     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1190     Document Type: Article

References (63)

1. Plat J, Mensink RP. Food components and immune function. Curr. Opin. Lipidol. 2005; 16: 31-37.
2. Conroy ME, Walker WA. Intestinal immune health. Nestle. Nutr. Workshop Ser. Pediatr. Program. 2008; 62: 111-121.
3. Korhonen H, Pihlanto A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr. Pharm. Des. 2007; 13: 829-843.
4. Berlutti F, Schippa S, Morea C, Sarli S, Perfetto B, Donnarumma G, Valenti P. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem. Cell Biol. 2006; 84: 351-357. DOI:10.1139/O06-039.
5. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell. Immunol. 2002; 220: 83-95. DOI:10.1016/S0008-8749(03)00006-6.
6. Filipp D, Alizadeh-Khiavi K, Richardson C, Palma A, Paredes N, Takeuchi O, Akira S, Julius M. Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proc. Natl. Acad. Sci. USA 2001; 98: 603-608.
7. Curran CS, Demick KP, Mansfield JM. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol. 2006; 242: 23-30. DOI:10.1016/j.cellimm.2006.08.006.
8. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, Ferrara P, Schiffrin EJ, Morgan BP, Labeta MO. Soluble formsof Toll-like receptor (TLR)2 capable of modulatingTLR2 signaling are present in human plasma and breast milk. J. Immunol. 2003; 171: 6680-6689.
9. LeBouder E, Rey-Nores JE, Raby AC, Affolter M, Vidal K, Thornton CA, Labeta MO. Modulation of neonatal microbial recognition: tlr-mediated innateimmuneresponses are specificallyanddifferentially modulated by human milk. J. Immunol. 2006; 176: 3742-3752.
10. Blais DR, Harrold J, Altosaar I. Killing the messenger in the nick of time: persistence of breast milk sCD14 in the neonatal gastrointestinal tract. Peditar. Res. 2006; 59: 371-376. DOI:10.1203/01.pdr.0000199907. 61549.94.
11. Vidal K, Labeta MO, Schiffrin EJ, Donnet-Hughes A. Soluble CD14 in human breast milk and its role in innate immune responses. Acta Odontol. Scand. 2001; 59: 330-334.
12. Labeta MO, Vidal K, Nores JE, Arias M, Vita N, Morgan BP, Guillemot JC, Loyaux D, Ferrara P, Schmid D, Affolter M, Borysiewicz LK, Donnet-Hughes A, Schiffrin EJ. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J. Exp. Med. 2000; 191: 1807-1812.
13. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 2006; 27: 352-357. DOI:10.1016/j.it.2006.06.003.
14. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007; 7: 179-190. DOI:10.1038/nri2038.
15. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J. Immunol. 2005; 174: 4453-4460.
16. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007; 7: 379-390. DOI:10.1038/nri2075.
17. Clare DA, Swaisgood HE. Bioactive milk peptides: a prospectus. J. Dairy Sci. 2000; 83: 1187-1195.
18. Pihlanto A, Korhonen H. Bioactive peptides and proteins. Adv. Food Nutr. Res. 2003; 47: 175-276. DOI:10.1016/S1043-4526(03)47004-6.
19. Silva SV, Malcata FX. Caseins as source of bioactive peptides. Int. Dairy J. 2005; 15: 1-15. DOI:10.1016/j.idairyj.2004.04.009.
20. Meisel H. Biochemical properties of peptides encrypted in bovine milk proteins. Curr. Med. Chem. 2005; 12: 1905-1919.
21. Hong F, Ming L, Yi S, Zhanxia L, Yongquan W, Chi L. The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 2008; 29: 1062-1071. DOI:10.1016/j.peptides.2008.02.005.
22. Otte JM, Kiehne K, Herzig KH. Antimicrobial peptides in innate immunity of the human intestine. Jpn. J. Gastroenterol. 2003; 38: 717-726. DOI:10.1007/s00535-003-1136-5.
23. YonedaM, Shiraishi J, Kuraishi T, Aoki F, Imakawa K, Sakai S. Gastric proteinase digestion of caseins in newborn pups of the mouse. J. Dairy Sci. 2001; 84: 1851-1855.
24. Ferranti P, Traisci MV, Picariello G, Nasi A, Boschi V, Siervo M, Falconi C, Chianese L, Addeo F. Casein proteolysis in human milk: tracing the pattern of casein breakdown and the formation of potential bioactive peptides. J. Dairy Res. 2004; 71: 74-87. DOI: 10.1017/S0022029903006599.
25. Miquel E, Gomez JA, Alegria A, Barbera R, Farre R, Recio I. Identification of casein phosphopeptides released after simulated digestion of milk-based infant formulas. J. Agric. Food Chem. 2005; 53: 3426-3433. DOI:10.1021/jf0482111.
26. Ohsawa K, Satsu H, Ohki K, Enjoh M, Takano T, Shimizu M. Producibility and digestibility of antihypertensive beta-casein tripeptides, val-pro-pro and ile-pro-pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. J. Agric. Food Chem. 2008; 56: 854-858. DOI:10.1021/jf072671n.
27. Minervini F, Algaron F, Rizzello CG, Fox PF, Monnet V, Gobbetti M. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol. 2003; 69: 5297-5305. DOI: 10.1128/AEM.69.9.5297-5305.2003.
28. Hernandez-Ledesma B, Amigo L, Ramos M, Recio I. Application of high-performance liquid chromatography-tandem mass spectrometry to the identification of biologically active peptides produced by milk fermentation and simulated gastrointestinal digestion. J. Chromatogr. A 2004; 1049: 107-114. DOI:10.1016/j.chroma.2004.07.025.
29. Prioult G, Pecquet S, Fliss I. Stimulation of interleukin-10 production by acidic beta-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clin. Diagn. Lab. Immunol. 2004; 11: 266-271. DOI: 10.1128/CDLI.11.2.266-271.2004.
30. De Noni I, Floris R. Specific release of Albutensins from bovine and human serum albumin. Int. Dairy J. 2007; 17: 504-512. DOI:10.1016/j.idairyj.2006.06.022.
31. Schmelzer CE, Schops R, Reynell L, Ulbrich-Hofmann R, Neubert RH, Raith K. Peptic digestion of beta-casein. Time course and fate of possible bioactive peptides. J. Chromatogr. A 2007; 1166: 108-115. DOI:10.1016/j.chroma.2007.08.015.
32. Klostermeyer H, Reimerdes EH. Heat induced crosslinks in milk proteins and consequences for the milk system. Adv. Exp. Med. Biol. 1977; 86B: 263-275.
33. Bens M, Bogdanova A, Cluzeaud F, MiquerolL, KerneisS, Kraehenbuhl JP, Kahn A, Pringault E, Vandewalle A. Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. Am. J. Physiol. 1996; 270: C1666-C1674.
34. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp.Med. 2002; 195: 559-570. DOI: 10.1084/jem.20011788.
35. Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 2003; 198: 1225-1235. DOI: 10.1084/jem.20022194.
36. Larsen LB, Rasmussen MD, Bjerring M, Nielsen JH. Proteases and protein degradation in milk from cows infected with Streptococcus uberis. Int. Dairy J. 2004; 14: 899-907. DOI:10.1016/j.idairyj.2004.03.006.
37. Wiking L, Frøst MB, Larsen LB, Nielsen JH. Effects of storage conditions on lipolysis, proteolysis and sensory attributes in high quality raw milk. Milchwissenschaft 2002; 57: 190-193.
38. Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J.Mass Spectrom. 1999; 34: 105-116.
39. LotzM,Konig T,Menard S, Gutle D,Bogdan C,HornefMW. Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology 2007; 122: 306-315. DOI: 10.1111/j.1365-2567. 2007.02639.x.
40. Lotz M, Gutle D, Walther S, Menard S, Bogdan C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp.Med. 2006; 203: 973-984. DOI: 10.1084/jem.20050625.
41. vanAubel RA,Keestra AM, Krooshoop DJ, van Eden W, van Putten JP. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells. Mol. Immunol. 2007; 44: 3702-3714. DOI:10.1016/j.molimm.2007.04.001.
42. Manukyan M, Triantafilou K, Triantafilou M, Mackie A, Nilsen N, Espevik T,Wiesmuller KH, Ulmer AJ, Heine H. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 2005; 35: 911-921. DOI:10.1002/eji.200425336.
43. Nakata T, Yasuda M, Fujita M, Kataoka H, Kiura K, Sano H, Shibata K. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol. 2006; 8: 1899-1909. DOI:10.1111/j.1462-5822.2006.00756.x.
44. Takada H, Uehara A. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr. Pharm. Des. 2006; 12: 4163-4172.
45. Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 2007; 44: 3100-3111. DOI:10.1016/j.molimm.2007.02.007.
46. NatsukaM, Uehara A, Shuhua Y, Echigo S, Takada H.Apolymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2-and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells. J. Innate. Immun. 2008; 14: 298-308. DOI:10.1177/175342908096518.
47. Dziarski R, Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 2005; 73: 5212-5216.DOI: 10.1128/IAI.73.8.5212-5216.2005.
48. Wu L, Feng BS, He SH, Zheng PY, Croitoru K, Yang PC. Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2. Immunol. Cell Biol. 2007; 85: 538-545. DOI:10.1038/sj.icb.7100079.
49. HuberM,Kalis C, Keck S, Jiang Z,Georgel P,Du X, Shamel L, Sovath S, Mudd S, Beutler B, Galanos C, FreudenbergMA. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells. Eur. J. Immunol. 2006; 36: 701-711.DOI:10.1002/eji.200535593.
50. Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J, Spik G. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 1995; 312(Pt 3): 839-845.
51. Hernandez-Ledesma B, Recio I, Amigo L. Beta-lactoglobulin as source of bioactive peptides. Amino Acids 2007; 35: 257-265. DOI:10.1007/s00726-007-0585-1.
52. Shimizu T, Kida Y, Kuwano K. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2. Immunology 2007; 121: 473-483. DOI: 10.1111/j.1365-2567. 2007.02594.x.
53. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130: 1071-1082. DOI:10.1016/j.cell.2007. 09.008.
54. Larsen LB, McSweeney PLH, Hayes MG, Andersen JB, Ingvartsen KL, Kelly AL. Variation in activity and heterogeneity of bovine milk proteases with stage of lactation and somatic cell count. Int. Dairy J. 2006; 16: 1-8. DOI:10.1016/j.idairyj.2005.01.009.
55. Madsen BD, Rasmussen MD, Nielsen MO, Wiking L, Larsen LB. Physical properties of mammary secretions in relation to chemical changes during transition from colostrum to milk. J. Dairy Res. 2004; 71: 263-272. DOI: 10.1017/S0022029904000263.
56. Reimerdes EH, Petersen F, Kielwein G. Milk proteinases. 9. Proteinases from casein micelles, milk serum, cow's blood serum and pseudomonas fluorescens. Milchwissenschaft 1979; 34: 551.
57. De Simone C, Picariello G, Mamone G, Stiuso P, Dicitore A, Vanacore D, Chianese L, Addeo F, Ferranti P. Characterisation and cytomodulatory properties of peptides from Mozzarella di Bufala Campana cheese whey. J. Pept. Sci. 2009; 15: 251-258.
58. Tobita K, Kawahara T, Otani H. Bovine beta-casein (1-28), a casein phosphopeptide, enhances proliferation and IL-6 expression of mouse CD19+ cells via Toll-like receptor 4. J. Agric. Food Chem. 2006; 54: 8013-8017. DOI:10.1021/jf0610864.
59. Ganjam LS, Thornton WH Jr, Marshall RT, MacDonald RS. Antiproliferative effects of yogurt fractions obtained bymembrane dialysis on culturedmammalianintestinal cells. J.DairySci. 1997;80:2325-2329.
60. Matar C, Valdez JC, Medina M, Rachid M, Perdigon G. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 2001; 68: 601-609. DOI: 10.1017/S0022029901005143.
61. Parker F, Migliore-Samour D, Floc'h F, Zerial A, Werner GH, Jolles J, Casaretto M, Zahn H, Jolles P. Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. Eur. J. Biochem. 1984; 145: 677-682. DOI:10.1111/j.1432-1033.1984.tb08609.x.
62. Migliore-Samour D, Floc'h F, Jolles P. Biologically active casein peptides implicated in immunomodulation. J. Dairy Res. 1989; 56: 357-362.
63. Sandre C, Gleizes A, Forestier F, Gorges-Kergot R, Chilmonczyk S, Leonil J, Moreau MC, Labarre C. A peptide derived from bovine betacasein modulates functional properties of bone marrow-derived macrophages from germfree and human flora-associated mice. J. Nutr. 2001; 131: 2936-2942.